Nasdaq

InVivo Therapeutics Announces FDA Acceptance of Preclinical Module in Support of Company ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord ...
Business Wire

InVivo Therapeutics Announces FDA Acceptance of Preclinical Module in Support of Company ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord ...